Disease / condition

Emotional Problem clinical trials

Free access to 6 studies·3+ countries·Updated daily3 recruiting
6
Total trials
3+
Countries
5+
Sponsors
3
Recruiting
By phase
N/A6
By status
Recruiting3
Completed1
Enrolling by in...1
Withdrawn1
Top countries
Romania3
Spain1
Taiwan1
Top sponsors
Babes-Bolyai Unive...2
Columbia Universit...1
Oana David1
St. Martin De Porr...1
Universidad Miguel...1
Recent trials
Latest clinical trials for Emotional Problem
NCT06419933Recruiting
Emotional Problems in Preschool Children: Evaluation of the SuperKids Program (PRE-KIDS)
Universidad Miguel Hernandez d...Spain
NCT05424900Recruiting
An Integrative Intervention for Preventing Children's Emotional Disorders
Oana DavidRomania
NCT04949620Recruiting
An Integrative Platform for Preventing Children's Emotional Disorders
Babes-Bolyai UniversityRomania
NCT05739760Withdrawn
Impact of Cuddle and Calm Booklets on Parent-Child Emotional Connection a Nurture-based Children's Book
Columbia University
NCT04788901Completed
Assessment of Emotion-regulation Skills in Game-based Situations
Babes-Bolyai UniversityRomania
NCT04371263Enrolling by...
How Dose Election Event Will Induce Emotion Change of Emergency Room and Critical Unit
St. Martin De Porress HospitalTaiwan
About this record

Access comprehensive clinical trial information for Emotional Problem through Pure Global AI's free database. This collection includes 6 clinical trials across multiple phases including N/A. Currently, 3 trials are actively recruiting participants.

Research for Emotional Problem is being conducted in Romania, Spain, Taiwan and more. Leading sponsors include Babes-Bolyai University and Columbia University. Pure Global AI offers free access to clinical trial data from ClinicalTrials.gov, WHO ICTRP, and regional registries worldwide.

Pure Global AI provides free access to 6 clinical trials studying Emotional Problem, aggregated from major global registries including ClinicalTrials.gov, WHO ICTRP, and regional databases.

The trials span multiple phases, from early Phase 1 safety studies to large-scale Phase 3 efficacy trials, conducted across 3+ countries.

Top research sponsors include Babes-Bolyai University, Columbia University, Oana David, among others.